Related Experiment Video
Updated: Apr 10, 2026

05:14
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.7K
Plant-derived flavonoids in ocular angiopathy
1Laboratory of Physiopathology of Obesity, Department of Medicine, University of Verona, Verona - Italy.
European Journal of Ophthalmology
|June 13, 2015
Summary
Flavonoids show promise in preventing blood vessel disease (angiopathy), but more human studies are needed. Randomized controlled trials are essential to confirm these benefits.
Area of Science:
- Biochemistry
- Pharmacology
- Clinical Medicine
Background:
- Flavonoids are plant compounds with demonstrated antioxidant and anti-inflammatory properties.
- In vitro and ex vivo studies suggest potential therapeutic effects of flavonoids in preventing vascular complications.
- Angiopathy, a complication of various diseases, involves damage to blood vessels.
Purpose of the Study:
- To evaluate the efficacy of flavonoids in preventing angiopathy.
- To bridge the gap between preclinical findings and clinical application of flavonoids.
- To determine the clinical relevance of flavonoid-based interventions for vascular health.
Main Methods:
- Systematic review of existing literature on flavonoid activity.
- Analysis of in vitro and ex vivo studies investigating flavonoid mechanisms.
- Identification of the need for randomized controlled trials (RCTs) to validate findings.
Main Results:
- Preclinical evidence strongly suggests that flavonoids possess anti-angiopathic properties.
- Current evidence predominantly stems from laboratory-based (in vitro) and outside-the-body (ex vivo) experiments.
- A significant need exists for robust clinical validation through human trials.
Conclusions:
- Flavonoid compounds show potential for preventing angiopathy.
- Translating promising in vitro/ex vivo findings into clinical practice requires rigorous RCTs.
- Future research should focus on well-designed human trials to confirm flavonoid efficacy in managing vascular conditions.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

